The company is a high-tech enterprise based on the regenerative medicine industry, expanding fields related to life and health, and grafting the world's high-end technical resources and achievements. It continues to lay out in biomaterials, cell/stem cells, pharmaceuticals, and advanced medical technology and product business fields. The core business forms a “3+1” pattern, namely the three major business segments of materials, cells, and pharmaceuticals, and a technology incubation platform. Since its establishment, the company has been following a firm path of original technology in the biomedical field, focusing on the fields of regenerative medicine and life health related industries, and grafting global high-end technical resources and achievements. The main products include biotype hard brain (spine) membrane patches, type B hard (spine) membrane supplements, sterile biological wound care films, Ario breast patches, thoracic surgery repair patches, and himbic benvermod cream. Corporate honors: 2008 China's top ten most valuable enterprises, two high and six new enterprises; 2008 China's top 30 enterprises with the most investment value; 2009 China's top 50 most valuable investment enterprises, etc., and won the “Charitable and Caring Enterprise” award issued by the Guangzhou Huangpu District Social Construction Promotion Association.
No Data